Intravenous midazolam for the treatment of refractory status epilepticus
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To determine the usefulness of midazolam as a therapeutic agent for status epilepticus refractory to conventional treatment. DESIGN: Retrospective study. SETTING: ICUs of two university hospitals. PATIENTS: Seven patients with refractory status epilepticus who failed treatment with diazepam, lorazepam, and phenytoin, with or without phenobarbital. All patients received mechanical ventilation before receiving midazolam. INTERVENTIONS: Intravenous midazolam by bolus administration followed by infusion. MEASUREMENTS AND MAIN RESULTS: Midazolam terminated status epilepticus in all patients in less than 100 secs, as determined by clinical observation (three patients) or electroencephalographic monitoring (four patients). One patient developed mild hypotension. CONCLUSIONS: In this small study, midazolam appears to be an effective and safe alternative to high-dose barbiturate coma for the termination of status epilepticus when conventional agents have failed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Midazolam has also been found to be safe and effective when administered as a continuous infusion to treat refractory generalized convulsive status epilepticus (129-133).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [130]
Citations
Cites
Still being checked.
Cited by
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Self-citationClaassen, J., Hirsch, L. J., Emerson, R. G., & Mayer, S. A. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.28501.x · Cited by 642
Lowenstein, D. H., & Alldredge, B. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804023381407 · Cited by 568
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Status epilepticus: pathophysiology and management in adults
Chen, J. W., & Wasterlain, C. G. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70374-x · Cited by 504
Metadata
- Authors
- KUMAR, A., & BLECK, T. P.
- Affiliations
- Health Sciences Centre (CA)
- University of Manitoba (CA)
- ORCID
- BLECK, THOMAS P.
- Venue
- Critical Care Medicine
- Published
- 1992-04
- Volume
- 20
- Issue
- 4
- Pages
- 483-488
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2083548898
- Cited by
- 169
- References
- 0
- Citations by year
- 2025: 3 · 2023: 1 · 2022: 2 · 2020: 1 · 2018: 4 · 2017: 2 · 2016: 5 · 2015: 2 · 2014: 5 · 2013: 3 · 2012: 4
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Keywords
- midazolam, refractory status epilepticus, intravenous midazolam, benzodiazepines, barbiturate coma, diazepam, lorazepam, phenytoin, phenobarbital, mechanical ventilation, hypotension, anticonvulsant therapy
- MeSH terms
- Adult, Anticonvulsants, Child, Child, Preschool, Drug Resistance, Electroencephalography, Female, Humans, Infant, Newborn, Infusions, Intravenous, Injections, Intravenous, Male, Midazolam, Retrospective Studies, Status Epilepticus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intravenous midazolam for the treatment of refractory status epilepticus. https://app.cochat.ai/papers/10.1097/00003246-199204000-00009
- The paper
- KUMAR, A., & BLECK, T. P. (1992). Intravenous midazolam for the treatment of refractory status epilepticus. Critical Care Medicine. https://doi.org/10.1097/00003246-199204000-00009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.